Practitioner Protocol for the Photoreduction of [14C]CO2 to [14C]CO and Its Application to the Aminocarbonylation of an Aryl Iodide

IF 0.9 4区 医学 Q4 BIOCHEMICAL RESEARCH METHODS
Quentin Lemesre, Augustin Malandain, Maxime Jay, David-Alexandre Buisson, Frédéric Taran, Antoine Sallustrau, Davide Audisio
{"title":"Practitioner Protocol for the Photoreduction of [14C]CO2 to [14C]CO and Its Application to the Aminocarbonylation of an Aryl Iodide","authors":"Quentin Lemesre,&nbsp;Augustin Malandain,&nbsp;Maxime Jay,&nbsp;David-Alexandre Buisson,&nbsp;Frédéric Taran,&nbsp;Antoine Sallustrau,&nbsp;Davide Audisio","doi":"10.1002/jlcr.70021","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Carbon-14 labeling is fundamentally important for supporting the development of new agrochemicals and pharmaceuticals. Given its critical importance, continued innovation in technologies and methodologies for radiolabeling should be strongly encouraged to better support the radiochemistry community. However, a persistent gap often exists between technological breakthroughs and their broad adoption by the scientific community. To help bridge this gap, we have developed a Practitioner Protocol detailing a recent method from our laboratory. This protocol describes how to produce <sup>14</sup>C-labeled carbon monoxide ([<sup>14</sup>C]CO) directly from the universal precursor, [<sup>14</sup>C]carbon dioxide ([<sup>14</sup>C]CO<sub>2</sub>). We hope this protocol will facilitate the adoption and implementation of this technology in other radiochemistry laboratories, thereby enhancing radiolabeling capabilities across the field.</p>\n </div>","PeriodicalId":16288,"journal":{"name":"Journal of labelled compounds & radiopharmaceuticals","volume":"69 2","pages":""},"PeriodicalIF":0.9000,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of labelled compounds & radiopharmaceuticals","FirstCategoryId":"3","ListUrlMain":"https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/jlcr.70021","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0

Abstract

Carbon-14 labeling is fundamentally important for supporting the development of new agrochemicals and pharmaceuticals. Given its critical importance, continued innovation in technologies and methodologies for radiolabeling should be strongly encouraged to better support the radiochemistry community. However, a persistent gap often exists between technological breakthroughs and their broad adoption by the scientific community. To help bridge this gap, we have developed a Practitioner Protocol detailing a recent method from our laboratory. This protocol describes how to produce 14C-labeled carbon monoxide ([14C]CO) directly from the universal precursor, [14C]carbon dioxide ([14C]CO2). We hope this protocol will facilitate the adoption and implementation of this technology in other radiochemistry laboratories, thereby enhancing radiolabeling capabilities across the field.

[14C]CO2光还原为[14C]CO及其在芳基碘化氨基羰基化中的应用的实践规程
碳-14标签对于支持新农用化学品和药品的开发至关重要。鉴于其至关重要,应大力鼓励放射性标签技术和方法的持续创新,以更好地支持放射化学界。然而,在技术突破与其被科学界广泛采用之间往往存在着持续的差距。为了帮助弥合这一差距,我们开发了一个从业者协议,详细介绍了我们实验室最近的一种方法。该方案描述了如何直接从通用前体[14C]二氧化碳([14C]CO2)生产14C标记的一氧化碳([14C]CO)。我们希望该协议将促进该技术在其他放射化学实验室的采用和实施,从而提高整个领域的放射性标记能力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.30
自引率
0.00%
发文量
57
审稿时长
1 months
期刊介绍: The Journal of Labelled Compounds and Radiopharmaceuticals publishes all aspects of research dealing with labeled compound preparation and applications of these compounds. This includes tracer methods used in medical, pharmacological, biological, biochemical and chemical research in vitro and in vivo. The Journal of Labelled Compounds and Radiopharmaceuticals devotes particular attention to biomedical research, diagnostic and therapeutic applications of radiopharmaceuticals, covering all stages of development from basic metabolic research and technological development to preclinical and clinical studies based on physically and chemically well characterized molecular structures, coordination compounds and nano-particles.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书